RecruitingNCT06810011

Eye Diseases "Treated" With Interoperable Medical Informatics

EyeMatics - Eye Diseases "Treated" With Interoperable Medical Informatics


Sponsor

University Hospital Muenster

Enrollment

2,000 participants

Start Date

Mar 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The overarching goal of EyeMatics is to promote an interoperable, sustainable infrastructure for the integration and sharing of data from clinical research to improve personalized medicine in ophthalmology. To achieve this, EyeMatics bundles the expertise and preliminary work of the four consortia of the Medical Informatics Initiative (MII) and the ophthalmological centers of excellence in Germany. The perspective and concerns of patients will be strongly incorporated into the project work through close cooperation with patient representatives and the inclusion of patient feedback on quality of life and treatment success. EyeMatics aims to improve the understanding of the therapeutic success of eye diseases that are usually treated with intravitreal surgical medication (IVOM). To this end, an exemplary analysis platform for "real" clinical data will be provided and a dashboard for data visualization and analysis will be developed as a web application. The dashboard is to be introduced at all participating hospital sites for research purposes.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • OPS code: "5-156.9 Injection of drugs into the posterior segment of the eye"

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(6)

Klinikum Chemnitz gGmbH

Chemnitz, Saxony, Germany

Universitätsklinikum Aachen, AöR

Aachen, Germany

Universitätsmedizin Greifswald

Greifswald, Germany

Universität Leipzig

Leipzig, Germany

Universität Münster

Münster, Germany

Universitätsklinikum Tübingen

Tübingen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06810011


Related Trials